Clinical Trial Update: Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing haloperidol to ondansetron for cannabis hyperemesis syndrome in cannabis use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Hyperemesis Syndrome
• Cannabis Use Disorder

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)
• Ondansetron (ondansetron)

Snippet

Sponsor: Dr. Marco L.A. Sivilotti | Conditions: Cannabis Use Disorder | Phase 4 | Status: COMPLETED